JP2017524712A5 - - Google Patents

Download PDF

Info

Publication number
JP2017524712A5
JP2017524712A5 JP2017507390A JP2017507390A JP2017524712A5 JP 2017524712 A5 JP2017524712 A5 JP 2017524712A5 JP 2017507390 A JP2017507390 A JP 2017507390A JP 2017507390 A JP2017507390 A JP 2017507390A JP 2017524712 A5 JP2017524712 A5 JP 2017524712A5
Authority
JP
Japan
Prior art keywords
injection
composition
particle
glucocorticoid
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017507390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017524712A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/043478 external-priority patent/WO2016025215A1/en
Publication of JP2017524712A publication Critical patent/JP2017524712A/ja
Publication of JP2017524712A5 publication Critical patent/JP2017524712A5/ja
Pending legal-status Critical Current

Links

JP2017507390A 2014-08-13 2015-08-03 角膜同種移植片拒絶および新血管形成を予防するためのグルココルチコイドを負荷したナノ粒子 Pending JP2017524712A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462037000P 2014-08-13 2014-08-13
US62/037,000 2014-08-13
US201562139561P 2015-03-27 2015-03-27
US62/139,561 2015-03-27
PCT/US2015/043478 WO2016025215A1 (en) 2014-08-13 2015-08-03 Glucocorticoid-loaded nanoparticles for prevention of corneal allograft rejection and neovascularization

Publications (2)

Publication Number Publication Date
JP2017524712A JP2017524712A (ja) 2017-08-31
JP2017524712A5 true JP2017524712A5 (enExample) 2018-08-16

Family

ID=54011072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017507390A Pending JP2017524712A (ja) 2014-08-13 2015-08-03 角膜同種移植片拒絶および新血管形成を予防するためのグルココルチコイドを負荷したナノ粒子

Country Status (8)

Country Link
US (1) US10195212B2 (enExample)
EP (1) EP3193827A1 (enExample)
JP (1) JP2017524712A (enExample)
KR (1) KR20170046146A (enExample)
CN (1) CN106794152A (enExample)
CA (1) CA2957764C (enExample)
MX (1) MX2017001863A (enExample)
WO (1) WO2016025215A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011106702A2 (en) 2010-02-25 2011-09-01 The Johns Hopkins University Sustained delivery of therapeutic agents to an eye compartment
JP6847848B2 (ja) 2014-12-15 2021-03-24 ザ ジョーンズ ホプキンズ ユニバーシティThe Johns Hopkins University スニチニブ製剤、及び緑内障の治療におけるその使用方法
EP3233098B1 (en) 2014-12-15 2024-05-29 The Johns Hopkins University Cvs transplantation for treatment of bacterial vaginosis
KR20240126072A (ko) 2015-01-27 2024-08-20 더 존스 홉킨스 유니버시티 점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제
KR20180058758A (ko) 2015-09-22 2018-06-01 그레이버그 비젼, 인크. 안구 장애의 치료를 위한 화합물 및 조성물
HK1257499A1 (zh) 2015-11-12 2019-10-25 Graybug Vision, Inc. 用於治疗的聚集性微粒
DE102017002454A1 (de) * 2017-03-14 2018-09-20 Friedrich-Schiller-Universität Jena Organische Polymerpartikel enthaltend Poly(oxazolin)-Stabilisatoren und Verwendung von Poly(oxazolinen) zur Stabilisierung von organischen Polymerpartikeln
EP3600324A4 (en) 2017-03-23 2020-12-09 Graybug Vision, Inc. COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS
AU2018265415A1 (en) 2017-05-10 2019-10-31 Graybug Vision, Inc. Extended release microparticles and suspensions thereof for medical therapy
WO2019071275A1 (en) * 2017-10-06 2019-04-11 Aciont Inc. DEVICES FOR DELIVERY OF NON-INVASIVE OCULAR MEDICINE
US12496279B2 (en) * 2019-04-11 2025-12-16 The Johns Hopkins University Nanoparticles for drug delivery to brain
US20230081539A1 (en) * 2020-02-21 2023-03-16 The Johns Hopkins University Suprachoroidal delivery of drug particles to reduce toxicity

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4888176A (en) 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4757128A (en) 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US4789724A (en) 1986-10-17 1988-12-06 Massachusetts Institute Of Technology Preparation of anhydride copolymers
US4857311A (en) 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
US4997652A (en) 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
WO2004084871A1 (en) * 2003-03-26 2004-10-07 Ltt Bio-Pharma Co., Ltd. Intravenous nanoparticles for targenting drug delivery and sustained drug release
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
US20050226814A1 (en) 2004-04-13 2005-10-13 Bausch & Lomb Incorporated Diagnostic method and kit for implantation of a sustained release drug-delivery implant with a steroid
US8246949B2 (en) * 2004-10-27 2012-08-21 Aciont, Inc. Methods and devices for sustained in-vivo release of an active agent
JP2007001926A (ja) * 2005-06-24 2007-01-11 Ltt Bio-Pharma Co Ltd 吸入・噴霧用ステロイド製剤
WO2007074604A1 (ja) * 2005-12-26 2007-07-05 Ltt Bio-Pharma Co., Ltd. 水溶性非ペプチド性低分子薬物含有ナノ粒子
WO2008139804A1 (ja) * 2007-05-14 2008-11-20 Ltt Bio-Pharma Co., Ltd. 徐放性の陰荷電基を持つ低分子薬物含有ナノ粒子
CN101970042A (zh) * 2008-02-25 2011-02-09 眼门药品公司 经由离子电渗法增强递送治疗药物至眼部组织
US20110206773A1 (en) * 2008-05-20 2011-08-25 Yale University Sustained delivery of drugs from biodegradable polymeric microparticles
US9095506B2 (en) 2008-11-17 2015-08-04 Allergan, Inc. Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
US20120177741A1 (en) 2009-09-29 2012-07-12 Eyegate Pharmaceuticals, Inc. Positively-charged poly (d,l-lactide-co-glycolide) nanoparticles and fabrication methods of the same
EP2755659A2 (en) 2011-09-13 2014-07-23 Altacor Limited Pharmaceutical nanoparticle compositions
EP2804632B1 (en) 2012-01-19 2019-09-18 The Johns Hopkins University Nanoparticle formulations with enhanced mucosal penetration
CN111700879A (zh) * 2012-05-03 2020-09-25 卡拉制药公司 显示提高的粘膜转移的药物纳米粒子

Similar Documents

Publication Publication Date Title
JP2017524712A5 (enExample)
Pan et al. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats
Salama et al. PLGA nanoparticles as subconjunctival injection for management of glaucoma
CN104136006B (zh) 悬浮在凝固性储库形成可注射药物制剂中的随时间推移而释放的生物可降解或生物可蚀解微球粒或微粒
JP6132964B2 (ja) 萎縮性加齢性黄斑変性の処置方法
CN104994815B (zh) 持续药物递送植入物
CA2957764C (en) Glucocorticoid-loaded nanoparticles for prevention of corneal allograft rejection and neovascularization
Wang et al. Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization
WO2003070219A1 (en) Drug delivery system for the subconjunctival administration of fine grains
JP2015007117A (ja) 眼内徐放型ドラッグ送達システムおよび眼症状を処置する方法
JP2020519585A5 (enExample)
JP2007535367A (ja) エストラジオール誘導体またはエストラトポン誘導体を含有する徐放性眼内インプラント、ならびに関連する製造法
Panda et al. RETRACTED: Self-assembled phenylalanine-α, β-dehydrophenylalanine nanotubes for sustained intravitreal delivery of a multi-targeted tyrosine kinase inhibitor
Sha et al. In situ gels: The next new frontier in ophthalmic drug delivery system
Bayram et al. Preparation and characterization of triamcinolone acetonide-loaded poly (3-hydroxybutyrate-co-3-hydroxyhexanoate)(PHBHx) microspheres
CN1835735A (zh) 微粒眼球筋膜下给药的药物释放系统
Godse et al. Polymeric nanoparticulate systems: A potential approach for ocular drug delivery
JP4487141B2 (ja) 微粒子テノン嚢下投与ドラッグデリバリーシステム
Abd et al. Nanomedicine-Based delivery to the posterior segment of the eye: Brighter tomorrow
민창희 IONTOPHORETIC DELIVERY OF DRUG-LOADED PLGA NANOPARTICLES TO THE PREOCULAR SURFACE FOR ENHANCED DRUG BIOAVAILABILITY
Lavik et al. Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
Pawar et al. Progress, prospect and explorations of polymeric nanoparticles for the treatment of ophthalmic complications
Fathollahzadeh Preparation and characterization of poloxamer407-gellan gum based ocular in situ hydrogels for co-delivery of antibiotics and corticosteroids
Tawfik Dual Drug-Loaded Electrospun Nanofibres for the Treatment of Corneal Diseases
RU2021117158A (ru) Улучшенные агрегированные микрочастицы